Drug and Vaccine Safety in Global Health: Global Medicines Program Report

A new report on drug and vaccine safety in global health, co-authored by Thomas Bollyky, Senior Fellow, Council for Foreign Relations, and Andy Stergachis, is now available. Funded by the Bill and Melinda Gates Foundation, this report is the product of the Safety Surveillance Working Group, a year-long initiative to develop a practical, scalable strategy for improving drug and vaccine safety in low- and middle-income countries.

Community Q&A On HIV Cures: An Outreach Worker's Perspective

With growing talk of an HIV cure, the defeatHIV Community Advisory Board, along with the University of Washington Center for AIDS Research, and BABES Network-YWCA worked together to put on a “Community Q & A on HIV Cures” event April 2 with visiting scientist Robert Siliciano, a Professor of molecular biology and genetics at Johns Hopkins University and one of the world’s leading researchers on HIV.

BIRCH team

Faculty Member Kenneth Stuart Receives Award for Leadership in Molecular Parasitology

Affiliate Professor Ken Stuart, PhD, has received the Alice and C.C. Wang Award in Molecular Parasitology, which recognizes scientific leaders currently making novel and significant discoveries on the biology of parasitic organisms. Dr. Stuart’s research is focused on trypanosomatid pathogens known to cause sleeping sickness, Chagas disease and leishmaniasis for which there are few effective treatments and no current vaccines. Read more.

BIRCH team

School of Public Health Annual Report features numerous Global Health Programs and People

The just-released School of Public Health 2013 Annual Report highlights many Department of Global Health collaborations across campus, such as the Human-Animal Medicine Project (Peter Rabinowitz, MD, MPH); the HOPE (home-based partner, education) project that tests mobile messaging for pregnant women in a Nairobi slum (Carey Farquhar, MD, MPH, and Global WACh or Center for Woman, Adolescent, and Child Health); and the expansion of the START (Strategic Analysis, Research & Training) program (Lisa Manhart

BIRCH team

NIH Awards $9.8M Grant to Research Consortium for HIV Vaccine Development

University of Washington is part of a consortium led by Seattle Biomed to develop a vaccine that would elicit broadly neutralizing antibodies against HIV-1. The $9.8m grant from NIH was announced March 10. Other members of the consortium include Seattle Children's Hospital and the Fred Hutchinson Cancer Research Center.

Seattle Biomed Scientific Director Leonidas Stamatatos, PhD, an Affiliate Professor of Global Health will serve as program principal investigator, and will lead the initial phase of the project, which includes the optimization of immunogens. 

Pages